|Practice Area||:||Information Lifecycle Governance & Security|
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Amgen utilizes IBM Maximo to monitor and manage assets. The explosive data growth within the Maximo environment was increasing system and storage costs, and deteriorating application performance. Over time, the data from Incidents/Service Requests grew dramatically, and there was a need for frequent backups. Application databases were continuing to collect more and more data at an increasing rate. If allowed to continue, uncontrolled data growth could have slowed the overall application performance, limited availability and seriously impacted operational efficiencies.
While evaluating possible solutions, Estuate’s Information Lifecycle Governance (ILG) specialists focused on controlling data growth. Estuate implemented a proven enterprise data management strategy for Amgen’s IBM Maximo environment using the Optim™ Data Growth Solution. The solution:
Estuate’s solution was designed specifically for the Client’s Maximo environment, and provided following key benefits:
Principal Information Systems Analyst.